Lars C Huber
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Rheumatology top 2%
- Rheumatoid Arthritis Research and Therapies
Papers in
- Co-authors
- Steffen GayOliver DistlerR E GayBeat A. MichelIngo H. TarnerThomas PapRenate E. GayJörg H. W. Distler
- Journals
- Allergy (3 papers)European Respiratory Journal (2 papers)Respiration (2 papers)Swiss Medical Weekly (2 papers)Nature Communications (1 paper)
- Partner nations
- SwitzerlandGermanyAustria
In The Last Decade
Lars C Huber
76 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 136
- Cancer Research 510
- Rheumatology 472
- Immunology 444
- Infectious Diseases 293
- Molecular Biology 1.1k
Countries citing papers authored by Lars C Huber
This map shows the geographic impact of Lars C Huber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars C Huber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars C Huber more than expected).
Fields of papers citing papers by Lars C Huber
This network shows the impact of papers produced by Lars C Huber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars C Huber. The network helps show where Lars C Huber may publish in the future.
Co-authors
The 25 scholars most cited alongside Lars C Huber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2022 | 38 | |
| 5 | 2022 | 5 | |
| 6 | 2022 | 0 | |
| 7 | 2022 | 3 | |
| 8 | 2020 | 83 | |
| 9 | 2019 | 0 | |
| 10 | 2015 | 5 | |
| 11 | 2014 | 3 | |
| 12 | 2013 | 1 | |
| 13 | 2013 | 1 | |
| 14 | 2013 | 11 | |
| 15 | 2011 | 81 | |
| 16 | 2009 | 4 | |
| 17 | 2009 | 365 | |
| 18 | 2009 | 12 | |
| 19 | 2007 | 11 | |
| 20 | Sorosphaera viticola sp. nov. (plasmodiophorids), an intracellular parasite in roots of grape vine. | 2005 | 6 |
About Lars C Huber
Lars C Huber is a scholar working on Endocrinology, Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine, Plant Science and Internal Medicine, having authored 86 papers that have together received 2.6k indexed citations. Recurring topics across this work include Pulmonary Hypertension Research and Treatments (14 papers), COVID-19 Clinical Research Studies (8 papers), Long-Term Effects of COVID-19 (7 papers), Horticultural and Viticultural Research (7 papers), MicroRNA in disease regulation (6 papers), Plant Disease Resistance and Genetics (6 papers), Plant Pathogens and Fungal Diseases (6 papers) and Transplantation: Methods and Outcomes (5 papers). The work is most often cited by research in Cancer Research (510 citations), Rheumatology (472 citations), Immunology (444 citations), Infectious Diseases (293 citations) and Molecular Biology (1.1k citations). Lars C Huber has collaborated with scholars based in Switzerland, Germany and Austria. Frequent co-authors include Steffen Gay, Oliver Distler, R E Gay, Beat A. Michel, Ingo H. Tarner, Thomas Pap, Renate E. Gay, Jörg H. W. Distler, Matthias Brock and Michelle Trenkmann. Their work appears in journals such as Allergy, European Respiratory Journal, Respiration, Swiss Medical Weekly and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.